ghk cu peptide storage 99% GHK-Cu Copper Powder CAS 49557-75-7 Cosmetic 1g Pack : Beauty & Personal Care Compounded GHK-Cu Troche — Restorative

Cross-contamination between peptide vials is the most common cause of unexplained potency loss in multi-peptide research protocols

OASIS trials: establishing effective doses Phase 2 OASIS 1 findings: Tested multiple dose levels: 0.3mg, 0.6mg, 1.2mg, 2.4mg, 4.5mg weekly Duration: 26 weeks Primary endpoint: Weight loss at each dose Dose-response results: 0.3mg weekly: ~4% body weight loss 0.6mg weekly: ~6% body weight loss 1.2mg weekly: ~8% body weight loss 2.4mg weekly: ~10% body weight loss 4.5mg weekly: ~12% body weight loss Key insight: Clear dose-response relationship

United States: Not FDA-approved

It is thought that lower levels influence impaired wound healing and immune dysfunction among other age-related declines